A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. TPS3639-TPS3639
Keyword(s):
2012 ◽
Vol 30
(15)
◽
pp. 1755-1762
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3517-3517
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3517-3517
◽
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3516-3516
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3541-3541
◽
Keyword(s):
2006 ◽
Vol 6
(4)
◽
pp. 261-264
◽
Keyword(s):